Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8 + T Cells in HCC.

MLA

Zhang, Yonghui, et al. “Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8 + T Cells in HCC.” Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 27, no. 11, Nov. 2019, pp. 1906–18. EBSCOhost, https://doi.org/10.1016/j.ymthe.2019.07.019.

APA

Zhang, Y., Zhang, H., Wei, M., Mou, T., Shi, T., Ma, Y., Cai, X., Li, Y., Dong, J., & Wei, J. (2019). Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8 + T Cells in HCC. Molecular Therapy : The Journal of the American Society of Gene Therapy, 27(11), 1906–1918. https://doi.org/10.1016/j.ymthe.2019.07.019

Chicago

Zhang, Yonghui, Hailin Zhang, Mei Wei, Tao Mou, Tao Shi, Yanyu Ma, Xinyu Cai, Yunzheng Li, Jie Dong, and Jiwu Wei. 2019. “Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8 + T Cells in HCC.” Molecular Therapy : The Journal of the American Society of Gene Therapy 27 (11): 1906–18. doi:10.1016/j.ymthe.2019.07.019.